Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

BioNTech has responded to a patent infringement lawsuit filed by fellow German biotech CureVac over its COVID-19 vaccine, saying it will "vigorously" defend itself. CureVac revealed yesterday that ...

GlaxoSmithKline and CureVac are to begin developing a next generation vaccine targeting emerging variants of the coronavirus – although it is unlikely to be ready until at least next year.

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Moderna MRNA announced that the U.S. government, through the Biomedical Advanced Research and Development Authority (“BARDA”) ...

After hours: 7:45:06 p.m. EST ...

As the bird flu virus continues to spread through the United States, the Trump administration on Tuesday ordered all ...